PHP28: HEALTH INVOLVEMENT: RELATIONSHIP WITH HEALTH STATUS AND PATIENT SATISFACTION  by Kulkarni, AS et al.
208 Abstracts
PHP26
INAPPROPRIATE PRESCRIPTION DRUG USE
AND REDUCED HEALTH STATUS FOR THE
ELDERLY
Fu AZ, Liu GG
University of North Carolina at Chapel Hill, Chapel Hill, NC,
USA
OBJECTIVE: Inappropriate prescribing is a major
problem for the elderly. This research is to ﬁll a gap in
literature exploring the impact of inappropriate medica-
tion use on patient health status. METHODS: Based 
on the 1996 national Medical Expenditure Panel Survey
(MEPS), inappropriate prescription drug use were identi-
ﬁed using Beers criteria. Ordered probit models were esti-
mated to quantify the impact of inappropriate drug use
on patient self-perceived health status. To minimize the
impact of endogeneity problem due to dynamic regres-
sion, a comprehensive set of prior health condition vari-
ables was included to capture the need conditions for
medical care. Complex survey sample design was adjusted
in modeling. RESULTS: As the modeling coefﬁcient
reaches the robustness, it provides strong evidence indi-
cating a signiﬁcant adverse impact of inappropriate pre-
scription drug use on patient self-perceived health status
(p < 0.01). After conducting the simulation, inappropri-
ate drug was found to increase the elderly with poor and
fair health status by 2.1 and 2.2 percentage points respec-
tively, compared to those with appropriate prescription
use. Meanwhile, the same effect decreases the elderly with
very-good and excellent health status by 1.9 and 2.8 per-
centage points respectively. CONCLUSIONS: This study
obtained strong evidence indicating that inappropriate
drug use can yield sizable adverse impact on patient
health status in the elderly. The result also helps to vali-
date the Beers criteria as valid proxy indicators of poor
prescribing practices leading to deterioration of health
status. Therefore, systematic policy actions are warranted
to reduce system medical errors in general and inappro-
priate prescribing in particular.
PHP27
HEALTH RELATED QUALITY OF LIFE AMONG
PRESCRIPTION DRUG USERS IN SWEDEN:AN
EPIDEMIOLOGICAL SURVEY
Isacson D, Bingefors K
Uppsala University, Uppsala, Sweden
OBJECTIVE: The aim was to study health related quality
of life (HRQoL) among users of prescription drugs in a
population. METHODS: Cross-sectional survey, 20–84
years, in the County of Uppland, Sweden. Five thousand
four hundred four (68%) answered the questionnaire. SF-
36 was used to measure HRQoL. Self-report with a recall
period of two weeks was used to estimate use of pre-
scription drugs. Linear regression analysis was employed
for the multivariate analyses controlling for age, sex and
co-medication. Non-users were used as the comparison
group. RESULTS: A total of 9.7% of the population used
drugs for hypertension, 9.5% analgesics, 6.6% hypnotics
and/or anxiolytics, 4.2% drugs for asthma, 3.6% drugs
for cardiac problems, 2.4% drugs for diabetes, 2.4% 
antidepressants, and 2.2% used drugs for angina. As
expected, users of different drugs had very different pat-
terns of decreased HRQoL. In the Physical Function (PF)
dimension users of drugs for angina had the lowest score
(-14.2) followed by users of analgesics (-12.3) and users
of drugs for diabetes (-7.2). Users of analgesics (21.6) and
users of drugs for angina (-17.8) had the lowest scores
on Role Physical (RP). Users of antidepressants (-19.4),
and users of hypnotics and/or anxiolytics (-17.6) scored
lowest in the Mental Health (MH) dimension. The lowest
Role Emotional (RE) scores were found among users of
antidepressants (-31.3), users of hypnotics and/or anxi-
olytics (-15.3) and users of drugs for angina (-9.3). The
lowest Social Function (SF) scores were found among
users of antidepressants (-16.1), and users of hypnotics
and/or anxiolytics (-14.5). CONCLUSIONS: Users of
prescription drugs have a reduced HRQoL, the pattern of
decrease as compared to the general population varies by
type of disease and drug use.
PHP28
HEALTH INVOLVEMENT: RELATIONSHIP WITH
HEALTH STATUS AND PATIENT SATISFACTION
Kulkarni AS1, Sansgiry SS1, Hayes D1, Rice GK2
1University of Houston, Houston,TX, USA; 2Kelsey Seybold
Clinics, Houston,TX, USA
OBJECTIVE: The purpose of this study was to evalu-
ate the relationships between health involvement, health
status, and patient satisfaction with health plan.
METHODS: A cross sectional study was conducted by
administering surveys to patients ﬁlling prescription at 10
Kelsey Seybold pharmacies located around Houston. The
surveys distributed were proportional to the prescription
volume of the pharmacies. Domains of consumer health
involvement were measured using an eight-item, previ-
ously validated health motivation scale as well as four-
items that measured involvement in health and health
plans using a 5-point strongly agree—strong disagree
scale. Health status was measured using the SF-12 scale
and patient satisfaction with health plan was measured
using an 8-item, 5-point Likert scale. Demographic data
such as age, gender, education, marital status, race, and
income were also obtained. Data were coded and ana-
lyzed using SAS statistical package at a set priori signiﬁ-
cance level of 0.05. Descriptive and correlation analysis
were conducted. RESULTS: Analyses was carried out on
326 usable surveys. Mean age of respondents was 45.28
± 13.35 years (range 21–93). Majority of the respondents
were female (71%) and enrolled in a health plan (94%).
Respondents in this study had high health motivation
scores (3.95 ± 0.67). They were highly involved in activ-
ities to improve their health (4.02 ± 0.75) and in select-
ing their health plan (3.86 ± 1.14). Overall respondents
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were satisﬁed with their health coverage (3.78 1.89).
Respondents in this study had low physical (PC) (47.23
± 9.69) and mental (MC) (47.11 ± 11.33) composite
scores on the SF-12 scale. There was a signiﬁcant corre-
lation between involvement in activities to improve health
and patient satisfaction scores. CONCLUSIONS: Con-
sumers were highly motivated to improve their health.
Health involvement could be used as a predictor of
humanistic outcomes in future studies.
PHP29
PREDICTIVE FACTORS OF INPATIENT DRUG
COSTS IN A MOTHER-CHILD TEACHING
HOSPITAL
Bussieres J1, Lebel D1, Dumont M2
1Université de Montréal, Montréal, QC, Canada;
2Sainte-Justine, Montréal, QC, Canada
OBJECTIVE: To identify predictive factors of inpatient
drug costs in a 500-bed mother-child teaching hospi-
tal. METHODS: All hospitalisations in 2000/2001 and
2001/2002 were evaluated. Categorical variables in-
cluded were major category of diagnosis (MCD) (n =
25), severity index (n = 4), risk index (n = 4) and patient
care units (n = 41). Continuous variables included were
patient weight (kg), level of intensity of resources utilised
(LIRU) and total inpatient drug costs/patient-year. Out-
liers were excluded: inpatient drug costs/patient-year
greater than 5000 $CDN, LIRU > 50 and MCD with less
than 10 patients per ﬁscal year. MCD were analysed 
as serial dichomotical variables. Data were extracted
from the admission and the pharmacy software system.
RESULTS: Analysis were based on a cohort of 8479
patients in 2000/2001 and 7355 patients in 2001/2002.
Cost was divided by patient’s body weight and log-
transformed. A stepwise block multiple regression was
processed in two blocks: a ﬁrst block included LIRU,
severity index and risk index and a second block added
relevant MCD. Cumulative R2 were respectively 29.3 and
33.5 for both ﬁscal year. The standardised weight of the
variables included for both years were similar. Individual
R2 were 15.7 and 19.4 for LIRU, 4.7 and 3.3 for sever-
ity index, 0.1 and 0.2 for risk index and 8.9 and 10.6 for
a selection of relevant MCD. A third of total inpatient
drug costs/patient-year can be explained by level of inten-
sity of resources utilised, some major category of diag-
nosis, severity index and risk index. CONCLUSIONS:
There are limited information published on predictive
factors of inpatient drug costs/patient-year in hospitals.
Further analyses are required to build a useful and
stronger model for planning and benchmarking drugs
costs in hospitals.
PHP30
RATES OF CONTINUATION OF NON
FORMULARY MEDICATIONS FOR CHRONIC
DISEASE SUFFERERS IN MULTI-TIERED
PHARMACY BENEFIT PLANS
Nair KV1,Valuck RJ1,Allen RR2
1University of Colorado Health Sciences Center, Denver, CO,
USA; 2Peak Statistical Services, Evergreen, CO, USA
OBJECTIVE: Evaluate the impact of 3-tier pharmacy
beneﬁt structures on medication switching patterns.
METHODS: The study design was a “pre”-test/”post”-
test quasi-experimental design with comparison groups
using chronic disease sufferers from a health plan in the
Western US. Individuals with 2 prescriptions for a non
formulary medication (n = 1729) were classiﬁed by their
pharmacy beneﬁt group as: a) 2-tier moving to a 3-tier
structure, (“converting” group); b) 2-tier staying in a 2-
tier structure; and c) 3-tier staying in a 3-tier structure.
The latter two were “comparison” groups. Two time
periods were studies: the “pre” period before and the
“post” period, after a change in pharmacy beneﬁt struc-
ture. Cox regressions, adjusting for age, gender, chronic
disease scores and pharmacy plan structure, assessed dif-
ferences in the continuation rates of non formulary med-
ications across all groups. RESULTS: Over 60% switched
to formulary alternatives when faced with increased co-
payments, of which 43.3% switched to a brand alter-
native (p < 0.001). Less than 10% discontinued their
medication. Cumulative continuation rate was higher 
for the converting group: 30.1% (95% CI 27.6%–
34.1%) and similar for members in the two-tier compar-
ison group: 26% (95% CI 21.2%–32.6%). Three-tier
comparison group members were half as likely to con-
tinue their non formulary medications during the post
period: 17.1% (95% CI 14.3%–20.4%). CONCLU-
SIONS: Individuals confronted with increased co-
payments due to the implementation of a three-tier plan
often switched their medications to formulary alterna-
tives. While this ﬁnding supports the general purpose of
three-tier structures, of concern is the potential impact on
individuals who discontinued their medications due to
these changes.
HEALTHCARE POLICY—Healthcare Expenditure
Studies (Including Productivity)
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WHAT WE HAVE MISUNDERSTOOD OF THE
HIGH RATE OF OUT-OF-POCKET PAYMENTS IN
HEALTH CARE SYSTEMS
Oh E, Imanaka Y, Ishizaki T
Kyoto University, Kyoto, Japan
OBJECTIVE: Among OECD countries Korea has the
highest rate of out-of-pocket payments (OOP) in the
health care system. This has been pointed out and sug-
gested that it should be much lower. This study investi-
